Genient Charts New Path with Landmark Partnership in Genomic Diagnostics

Genient, a clinical genomics company, embarks on a significant new phase with enhanced leadership and an exclusive distribution partnership with AIT Biotech of Singapore. This positions the company as a key player in India's life sciences sector, committed to providing accessible and equitable genomic diagnostics across the country.

Genient, a Noida-based leader in clinical genomics, is steering into a pivotal chapter marked by strengthened leadership and a groundbreaking distribution deal with AIT Biotech, Singapore. This partnership aims to enhance the availability of advanced genomic diagnostics in India, fulfilling a critical demand in the country's healthcare landscape.

Under the strategic vision of Mr. Anil Kumar and the recent appointment of Mr. Brijesh Singh as CEO, Genient is poised to transition effectively from technology services to a focused role in genomics. This alignment recognizes India's growing need for precise, data-driven diagnostics in clinical settings.

Genient's agreement with AIT Biotech will provide Indian laboratories with cutting-edge genomic solutions, including high-throughput sequencers and integrated informatics platforms. This collaboration is a strategic effort to democratize access to world-class diagnostics across India's diverse healthcare infrastructure.